Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly AML Patients”

189 trials

Showing 20 of 189 results

Testing effectiveness (Phase 2)UnknownNCT00354276
What this trial is testing

VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Vion Pharmaceuticals 85
Testing effectiveness (Phase 2)Ended earlyNCT01113502
What this trial is testing

Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia (AML)
Abramson Cancer Center at Penn Medicine 44
Not applicableUnknownNCT02432872
What this trial is testing

Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years

Who this might be right for
Acute Myeloid Leukemia
Jianxiang Wang 300
Testing effectiveness (Phase 2)Ended earlyNCT04914676
What this trial is testing

Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission

Who this might be right for
Acute Myeloid Leukemia
University of Florida 5
Large-scale testing (Phase 3)Study completedNCT00931138
What this trial is testing

Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association 420
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507825
What this trial is testing

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Who this might be right for
Acute Myeloid Leukemia (AML)
First People's Hospital of Hangzhou 61
Not applicableStudy completedNCT00554489
What this trial is testing

Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

Who this might be right for
Leukemia
Wake Forest University Health Sciences 26
Testing effectiveness (Phase 2)Study completedNCT02831192
What this trial is testing

Microtransplantation in Older Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 150
Not applicableNot Yet RecruitingNCT07563920
What this trial is testing

TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 93
Large-scale testing (Phase 3)Not Yet RecruitingNCT07469046
What this trial is testing

VAH vs VA in Newly Diagnosed Elderly AML

Who this might be right for
Acute Myeloid Leukemia (AML)Elderly Patients (60-75 Years)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 308
Early research (Phase 1)Study completedNCT01149408
What this trial is testing

Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid LeukemiaAML
University of Utah 3
Testing effectiveness (Phase 2)Study completedNCT01301820
What this trial is testing

Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)

Who this might be right for
Acute Myeloid Leukemia
French Innovative Leukemia Organisation 120
Large-scale testing (Phase 3)WithdrawnNCT01067274
What this trial is testing

ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association
Testing effectiveness (Phase 2)Study completedNCT00003673
What this trial is testing

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

Who this might be right for
Leukemia
Pfizer 55
Testing effectiveness (Phase 2)Study completedNCT00373373
What this trial is testing

Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia
University Hospital Muenster 200
Large-scale testing (Phase 3)UnknownNCT02171117
What this trial is testing

Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 196
Not applicableStudy completedNCT03350152
What this trial is testing

Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.

Who this might be right for
Acute Myeloid Leukemia
Hospices Civils de Lyon 302
Large-scale testing (Phase 3)UnknownNCT02985372
What this trial is testing

Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, Adult
Chunyan Ji 30
Not applicableUnknownNCT01188330
What this trial is testing

Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival

Who this might be right for
Acute Myeloid Leukemia
Institut Paoli-Calmettes 100
Large-scale testing (Phase 3)UnknownNCT04490707
What this trial is testing

Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML

Who this might be right for
Acute Myeloid Leukemia in Remission
Ge Zheng 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation